Kaplan-Meier and log-rank tests revealed no strong associations between ZKSCAN3 expression and a risk for the recurrence of non-muscle-invasive tumors (P=0.880), disease progression in all cases (P=0.170), or cancer-specific mortality in patients with muscle-invasive tumor who underwent radical cystectomy (P=0.678). Here, ZKSCAN3 is linked to cancer.